Hospital_Acquired_Pneumonia_Presentation_with_XRays.pptx

AbhishekNirmalkar1 0 views 14 slides Oct 07, 2025
Slide 1
Slide 1 of 14
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14

About This Presentation

Everything you want to know about pneumonia


Slide Content

Hospital Acquired Pneumonia (HAP) Definition, Anatomy, Pathophysiology, Pharmacology, Treatment & Criteria

Definition & Epidemiology - Pneumonia developing ≥48 hours after hospital admission - Not incubating at time of admission - 2nd most common nosocomial infection - High morbidity & mortality, esp. in ICU patients

Relevant Anatomy - Respiratory tract: nasal cavity → trachea → bronchi → alveoli - Normal defense: mucociliary clearance, alveolar macrophages - Intubation & impaired clearance increase risk

Pathophysiology - Aspiration of colonized oropharyngeal secretions - Impaired host defenses in hospitalized patients - Biofilm formation on endotracheal tubes - Inflammatory response → alveolar consolidation

Risk Factors - Mechanical ventilation (>48h) - Prolonged hospitalization - Broad-spectrum antibiotic use - Immunosuppression - Advanced age, chronic illness

Clinical Features & Diagnosis - Fever, purulent sputum, leukocytosis - New/progressive infiltrate on chest X-ray - Hypoxemia - Diagnostic tools: sputum culture, BAL, blood culture

Distinguishing Criteria - HAP: ≥48h after admission - CAP: community onset, before 48h - VAP: pneumonia after ≥48h of mechanical ventilation - HCAP: healthcare-associated (dialysis, nursing home, etc.)

Microbiology - Gram-negative bacilli: Pseudomonas, Klebsiella, E. coli - Gram-positive: MRSA - Polymicrobial in ICU cases - MDR pathogens are common

Pharmacology - Empiric therapy: cover Pseudomonas & MRSA if risk present - Beta-lactams (piperacillin-tazobactam, cefepime) - Carbapenems (meropenem) - Vancomycin/linezolid (MRSA coverage) - Aminoglycosides (synergistic use)

Treatment Protocol - Initial empiric broad-spectrum antibiotics - Tailor based on culture results - Duration: 7–10 days (shorter if good response) - Supportive care: oxygen, fluids, physiotherapy

Complications & Prognosis - Lung abscess, empyema - Sepsis, multiorgan failure - Mortality higher in ICU and MDR infections

Prevention Strategies - Hand hygiene & infection control - Elevation of head of bed (30–45°) - Oral care with chlorhexidine - Minimizing ventilator days - Judicious antibiotic use

Summary - HAP: pneumonia ≥48h after admission - Pathophysiology: aspiration, impaired defenses - MDR organisms frequent - Early recognition + empiric therapy essential - Prevention reduces incidence & mortality

Chest X-rays in Hospital Acquired Pneumonia Image 1: HAP X-ray Image 2: HAP X-ray Image 3: HAP X-ray Image 4: HAP X-ray
Tags